Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

      SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

      Medical Dialogues Bureau25 Feb 2020 1:06 PM IST
      California: SoftBank's second Vision Fund has led a new $165 million funding round in California-based Karius, which markets a test that can quickly...
      Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS

      Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS

      Medical Dialogues Bureau25 Feb 2020 1:03 PM IST
      "With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
      BA/BE study applications have to be processed in 15 days: CDSCO

      BA/BE study applications have to be processed in 15 days: CDSCO

      Medical Dialogues Bureau25 Feb 2020 12:50 PM IST
      New Delhi: In order to streamline the applications process by various pharma companies, the CDSCO in its notice has recently mandated that BA/BE...
      Aurobindo Pharma gets USFDA nod for Azithromycin 250 mg and 500 mg

      Aurobindo Pharma gets USFDA nod for Azithromycin 250 mg and 500 mg

      Medical Dialogues Bureau24 Feb 2020 2:22 PM IST
      New Delhi: Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture and market Azithromycin tablets, used for the...
      Coronavirus: Restrictions imposed on the export of medical equipment to China

      Coronavirus: Restrictions imposed on the export of medical equipment to China

      Medical Dialogues Bureau24 Feb 2020 12:29 PM IST
      New Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
      Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations

      Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations

      Medical Dialogues Bureau24 Feb 2020 12:18 PM IST
      Chennai: Solara Active Pharma Science Limited (Solara), an active Pharmaceutical Ingredient provider has announced that the US Food and Drug...
      Biocons Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations

      Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations

      Medical Dialogues Bureau24 Feb 2020 12:11 PM IST
      Malaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...
      USFDA approves Eli Lillys Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient

      USFDA approves Eli Lilly's Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient

      Medical Dialogues Bureau23 Feb 2020 12:00 PM IST
      New indication reflects a distinct patient population in the REWIND study, including primary people with multiple cardiovascular risk factors but...
      AIIMS director kickstarts three day International Conference at Delhi Pharmaceutical Sciences and Research University

      AIIMS director kickstarts three day International Conference at Delhi Pharmaceutical Sciences and Research University

      Medical Dialogues Bureau23 Feb 2020 12:00 PM IST
      New Delhi: Delhi Pharmaceutical Sciences and Research University (DPSRU) is hosting a three day International Conference of Cardiovascular Sciences-...
      FDA approves Lundbecks intravenous migraine prevention drug Vyepti, to launch in April 2020

      FDA approves Lundbeck's intravenous migraine prevention drug Vyepti, to launch in April 2020

      Medical Dialogues Bureau23 Feb 2020 11:30 AM IST
      Deerfield: Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) has been approved by the U.S. Food and Drug Administration (FDA) for the preventive...
      Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative Pain

      Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for Management of Postoperative Pain

      Medical Dialogues Bureau23 Feb 2020 9:30 AM IST
      SAN DIEGO : Heron Therapeutics, Inc,. a commercial-stage biotechnology company focused on improving the lives of patients by developing...
      Strides Consumer forays into North India market

      Strides Consumer forays into North India market

      Medical Dialogues Bureau22 Feb 2020 4:29 PM IST
      As part of the foray, the company has launched two products -- Nixit, and oral nicotine replacement therapy (NRT) product, and Jointflex, a topical...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok